POSTER: MPN-756: CPX-351 vs Standard of Care as Bridging to AlloHCT in Patients With Higher-Risk Myelodysplastic Neoplasms or Oligoblastic Acute Myeloid Leukemia: Results of the Randomized Phase 2 PALOMA Study

Clinical Lymphoma Myeloma & Leukemia 2026

View at publisher
Authors: Uwe Platzbecker, Martina Crysandt, Martin Kaufmann, Andreas Rank, Christoph Röllig, Hartmut Döhner, Gesine Bug, Katharina Götze, Felicitas R. Thol, Tobias A.W. Holderried, Judith Niederland, Mathias Häne
+24 more Stefan Klein, Christian Junghanss, Wolfgang Bethge, Knut Wendelin, Thomas Schroeder, Sigrid Machherndl‐Spandl, Ulrich Germing, Tim Sauer, Inken Hilgendorf, Dirk Niemann, Anne Sophie Platzbecker, Georg‐Nikolaus Franke, Katja Sockel, Susann Leupold, Martin Puttrich, Silke Gloaguen, Sandra SL Roldan P, Hubert Serve, Carsten Müller‐Tidow, Klaus Metzeler, Martin Bornhäuser, Wolf‐Karsten Hofmann, Richard Schlenk, Madlen Jentzsch
DOI: 10.1016/s2152-2650(26)00951-1
Cited by: 1

Fields of Study & Subjects

Acute Myeloid Leukemia Research Myeloproliferative Neoplasms: Diagnosis and Treatment Multiple Myeloma Research and Treatments

Publication details

Journal / source
Clinical Lymphoma Myeloma & Leukemia
Publisher
Elsevier BV
Volume
26
Pages
S283–S284
Publication date
1 August 2026
Language
EN